The GLP-1 Program is a strategic move following challenges w...
The GLP-1 Program is a strategic move following challenges with membership decline as GLP-1 drugs gained popularity. This shift and acquisition of Sequence could potentially help the company in reclaiming lapsed users according to Goldman Sachs analyst Jason English.
WeightWatchers Has a New $99 Monthly Plan - and It's Targeting Those on Drugs Like Ozempic and Wegovy
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3239Followers
0Following
8005Visitors
Follow